Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.

Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R; CDC; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2004 Mar 26;53(RR-3):1-36.

2.

Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee.

Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD.

Infect Control Hosp Epidemiol. 1998 Jun;19(6):407-63. No abstract available. Erratum in: Infect Control Hosp Epidemiol 1998 Jul;19(7):493.

PMID:
9669622
3.

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.

Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ.

JAMA. 1996 Jan 17;275(3):234-40. Review.

PMID:
8604178
4.

Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention.

Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM.

Infect Control Hosp Epidemiol. 1994 Sep;15(9):587-627. No abstract available. Erratum in: Infect Control Hosp Epidemiol 1998 May;19(5):304.

PMID:
7989733
5.

Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention.

Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM.

Am J Infect Control. 1994 Aug;22(4):247-92. No abstract available. Erratum in: Am J Infect Control 1994 Dec;22(6):351. Am J Infect Control 1994 Oct;22(5):324.

PMID:
7985826
6.

Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis.

Pegues DA, Schidlow DV, Tablan OC, Carson LA, Clark NC, Jarvis WR.

Arch Pediatr Adolesc Med. 1994 Aug;148(8):805-12.

PMID:
7519103
7.

Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group.

Pegues DA, Carson LA, Tablan OC, FitzSimmons SC, Roman SB, Miller JM, Jarvis WR.

J Pediatr. 1994 May;124(5 Pt 1):694-702.

PMID:
7513755
8.

Nosocomially acquired Pseudomonas cepacia infection in patients with cystic fibrosis.

Tablan OC.

Infect Control Hosp Epidemiol. 1993 Mar;14(3):124-6. No abstract available.

PMID:
7683030
9.

Aspergillus fumigatus sternal wound infections in patients undergoing open heart surgery.

Richet HM, McNeil MM, Davis BJ, Duncan E, Strickler J, Nunley D, Jarvis WR, Tablan OC.

Am J Epidemiol. 1992 Jan 1;135(1):48-58.

PMID:
1736660
10.

A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery.

Richet HM, Craven PC, Brown JM, Lasker BA, Cox CD, McNeil MM, Tice AD, Jarvis WR, Tablan OC.

N Engl J Med. 1991 Jan 10;324(2):104-9. No abstract available.

11.

Mycobacterium gordonae pseudoinfection associated with a contaminated antimicrobial solution.

Tokars JI, McNeil MM, Tablan OC, Chapin-Robertson K, Patterson JE, Edberg SC, Jarvis WR.

J Clin Microbiol. 1990 Dec;28(12):2765-9.

12.

Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center.

Komshian SV, Tablan OC, Palutke W, Reyes MP.

Rev Infect Dis. 1990 Jul-Aug;12(4):693-702.

PMID:
2385771
13.

Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

Carson LA, Tablan OC, Cusick LB, Jarvis WR, Favero MS, Bland LA.

J Clin Microbiol. 1988 Oct;26(10):2096-100.

14.

The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Tablan OC, Martone WJ, Jarvis WR.

Eur J Epidemiol. 1987 Dec;3(4):336-42. Review.

PMID:
3319668
15.

The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Martone WJ, Tablan OC, Jarvis WR.

Eur J Epidemiol. 1987 Sep;3(3):222-32. Review.

PMID:
3308510
16.

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

Tablan OC, Martone WJ, Doershuk CF, Stern RC, Thomassen MJ, Klinger JD, White JW, Carson LA, Jarvis WR.

Chest. 1987 Apr;91(4):527-32.

PMID:
3829745
17.
18.

Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy.

Weems JJ Jr, Davis BJ, Tablan OC, Kaufman L, Martone WJ.

Infect Control. 1987 Feb;8(2):71-5.

PMID:
3470268
19.

Infection control in pulmonary function laboratories.

Tablan OC, Williams WW, Martone WJ.

Infect Control. 1985 Nov;6(11):442-4. No abstract available.

PMID:
3851785
20.

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, Morgan WM, Carson LA, Martone WJ, Jason JM, et al.

J Pediatr. 1985 Sep;107(3):382-7.

PMID:
4032134
21.

Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia.

Tablan OC, Reyes MP.

Am J Med. 1985 Aug;79(2):268-70.

PMID:
4025379
22.

Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.

Tablan OC, Reyes MP, Rintelmann WF, Lerner AM.

J Infect Dis. 1984 Feb;149(2):257-63.

PMID:
6421944

Supplemental Content

Loading ...
Support Center